Published in Nat Rev Immunol on September 01, 2009
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum (2011) 3.81
The follicular versus marginal zone B lymphocyte cell fate decision. Nat Rev Immunol (2009) 2.80
Ibrutinib inhibits BCR and NF-κB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL. Blood (2014) 2.40
The B Cell-Stimulatory Cytokines BLyS and APRIL Are Elevated in Human Periodontitis and Are Required for B Cell-Dependent Bone Loss in Experimental Murine Periodontitis. J Immunol (2015) 2.02
Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease. Immunol Rev (2011) 1.70
Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice. Proc Natl Acad Sci U S A (2014) 1.32
Wiskott-Aldrich Syndrome protein deficiency perturbs the homeostasis of B-cell compartment in humans. J Autoimmun (2013) 1.07
Aberrant B-cell homeostasis in chronic GVHD. Blood (2015) 1.06
Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapy. J Clin Invest (2012) 1.06
Vitamin A and retinoic acid in the regulation of B-cell development and antibody production. Vitam Horm (2011) 1.04
B cells in chronic graft-versus-host disease. Biol Blood Marrow Transplant (2014) 0.99
The dynamic distribution of CARD11 at the immunological synapse is regulated by the inhibitory kinesin GAKIN. Mol Cell (2010) 0.98
Quantitative differences in CD45 expression unmask functions for CD45 in B-cell development, tolerance, and survival. Proc Natl Acad Sci U S A (2011) 0.97
Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency. Front Immunol (2012) 0.97
B cells and transplantation tolerance. Nat Rev Nephrol (2010) 0.97
B-lymphocyte lineage cells and the respiratory system. J Allergy Clin Immunol (2013) 0.89
G alpha q-containing G proteins regulate B cell selection and survival and are required to prevent B cell-dependent autoimmunity. J Exp Med (2010) 0.89
A pathway switch directs BAFF signaling to distinct NFκB transcription factors in maturing and proliferating B cells. Cell Rep (2014) 0.89
B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol (2015) 0.86
Resolve, revise, and relax: the 3 Rs of B cell repertoire adjustment. Immunol Lett (2012) 0.86
AR-regulated TWEAK-FN14 pathway promotes prostate cancer bone metastasis. Cancer Res (2014) 0.85
A hypomorphic IgH-chain allele affects development of B-cell subsets and favours receptor editing. EMBO J (2011) 0.84
Antibodies against CD20 or B-cell receptor induce similar transcription patterns in human lymphoma cell lines. PLoS One (2011) 0.83
FCRL5 exerts binary and compartment-specific influence on innate-like B-cell receptor signaling. Proc Natl Acad Sci U S A (2013) 0.83
B-cell development and functions and therapeutic options in adenosine deaminase-deficient patients. J Allergy Clin Immunol (2014) 0.83
Differences in mouse and human nonmemory B cell pools. J Immunol (2014) 0.80
Recruitment of a distinct but related set of VH sequences into the murine CD21hi/CD23- marginal zone B cell repertoire to that seen in the class-switched antibody response. J Immunol (2011) 0.79
B-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation. Transplant Rev (Orlando) (2010) 0.79
Midkine as a regulator of B cell survival in health and disease. Br J Pharmacol (2014) 0.79
Protein kinase Cβ is required for lupus development in Sle mice. Arthritis Rheum (2013) 0.78
TGFβ activated kinase 1 (TAK1) at the crossroad of B cell receptor and Toll-like receptor 9 signaling pathways in human B cells. PLoS One (2014) 0.77
CD21(int) CD23(+) follicular B cells express antigen-specific secretory IgM mRNA as primary and memory responses. Immunology (2017) 0.75
BCR and co-receptor crosstalk facilitate the positive selection of self-reactive transitional B cells. Curr Opin Immunol (2015) 0.75
Overexpression of MyrAkt1 in endothelial cells leads to erythropoietin- and BMP4-independent splenic erythropoiesis in mice. PLoS One (2013) 0.75
Intracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and Autoimmunity. Clin Rev Allergy Immunol (2017) 0.75
Revisiting the Page & Schroeder model: the good, the bad and the unknowns in the periodontal host response 40 years later. Periodontol 2000 (2017) 0.75
NLR Nod1 signaling promotes survival of BCR-engaged mature B cells through up-regulated Nod1 as a positive outcome. J Exp Med (2017) 0.75
NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol (1998) 21.48
Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol (2000) 20.70
Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science (2001) 7.66
In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell (1997) 7.18
Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med (2002) 7.11
IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci U S A (2001) 6.91
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature (2000) 6.54
BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science (1999) 5.99
New regulators of NF-kappaB in inflammation. Nat Rev Immunol (2008) 5.79
BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol (2002) 5.09
Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity (2004) 4.42
Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature (1994) 4.36
Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. Cell (2004) 4.31
Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature (1991) 4.04
Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity (2004) 4.00
Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat Immunol (2003) 3.82
Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity (2006) 3.74
Most peripheral B cells in mice are ligand selected. J Exp Med (1991) 3.50
BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med (2000) 3.43
CD40 regulates the processing of NF-kappaB2 p100 to p52. EMBO J (2002) 3.30
TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. Immunity (2008) 3.03
Aberrant B cell development and immune response in mice with a compromised BCR complex. Science (1996) 3.01
Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J Exp Med (2000) 3.00
Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J Exp Med (1998) 2.78
Initiation and processing of signals from the B cell antigen receptor. Annu Rev Immunol (1997) 2.77
TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J Immunol (2004) 2.51
Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. Immunity (2006) 2.33
Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs. Immunity (2007) 2.17
Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators. J Immunol (2002) 2.16
Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med (1994) 2.15
Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat Immunol (2003) 2.05
B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J Exp Med (1998) 2.00
Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling. Nat Immunol (2008) 1.96
IkappaB kinase signaling is essential for maintenance of mature B cells. J Exp Med (2002) 1.93
BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact. Proc Natl Acad Sci U S A (2008) 1.88
Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras. Proc Natl Acad Sci U S A (1989) 1.75
Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-kappa B-inducing kinase. J Immunol (2000) 1.70
Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells. Nat Immunol (2003) 1.70
The subunit composition of NF-kappa B complexes changes during B-cell development. Cell Growth Differ (1994) 1.62
Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation. J Exp Med (2008) 1.55
Competition for BLyS-mediated signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers. Curr Biol (2001) 1.49
Crosstalk via the NF-kappaB signaling system. Cytokine Growth Factor Rev (2008) 1.48
TCR and IL-7 receptor signals can operate independently or synergize to promote lymphopenia-induced expansion of naive T cells. J Immunol (2002) 1.44
Cutting edge: B cell receptor signals regulate BLyS receptor levels in mature B cells and their immediate progenitors. J Immunol (2003) 1.42
TCR signals mediated by Src family kinases are essential for the survival of naive T cells. J Immunol (2002) 1.41
Bcmd governs recruitment of new B cells into the stable peripheral B cell pool in the A/WySnJ mouse. J Immunol (1996) 1.40
NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells. J Immunol (2003) 1.38
Control of B lymphocyte apoptosis by the transcription factor NF-kappaB. Immunity (2006) 1.37
A novel mutation in the Nfkb2 gene generates an NF-kappa B2 "super repressor". J Immunol (2007) 1.34
NF-kappaB activation by protein kinase C isoforms and B-cell function. EMBO Rep (2003) 1.30
Bcmd decreases the life span of B-2 but not B-1 cells in A/WySnJ mice. J Immunol (1998) 1.29
Signaling for survival and apoptosis in the immune system. Arthritis Res (2002) 1.28
Bruton's tyrosine kinase mediates NF-kappa B activation and B cell survival by B cell-activating factor receptor of the TNF-R family. J Immunol (2007) 1.19
The role of BLyS/BLyS receptors in anti-chromatin B cell regulation. Int Immunol (2007) 1.18
Physiology of B cells in mice with X-linked immunodeficiency (xid). III. Disappearance of xid B cells in double bone marrow chimeras. J Exp Med (1984) 1.08
Survival signaling in resting B cells. Curr Opin Immunol (2004) 1.07
The role of cellular competition in B cell survival and selection of B cell repertoires. Eur J Immunol (1995) 1.02
Transitional B cells exhibit a B cell receptor-specific nuclear defect in gene transcription. J Immunol (2009) 1.01
Receptor-specific induction of NF-kappaB components in primary B cells. Int Immunol (1998) 1.00
B cell receptor-mediated sustained c-Rel activation facilitates late transitional B cell survival through control of B cell activating factor receptor and NF-kappaB2. J Immunol (2009) 0.97
Signal transduction by the B-cell antigen receptor. Ann N Y Acad Sci (1995) 0.91
Memories are made of this: synergy of T cell receptor and cytokine signals in CD4(+) central memory cell survival. Trends Immunol (2007) 0.83